Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Mosaic ImmunoEngineering Inc. (CPMV) had Income from Continuous Operations of $-0.18M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.18M |
|
-- |
|
-- |
|
$0.17M |
|
$-0.17M |
|
$-0.01M |
|
$-0.18M |
|
$-0.18M |
|
$-0.18M |
|
|
Income from Continuous Operations |
$-0.18M |
$-0.18M |
|
$-0.18M |
|
$-0.17M |
|
$-0.17M |
|
7.24M |
|
7.24M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$0.10M |
|
-- |
|
-- |
|
$0.10M |
|
$5.66M |
|
$1.41M |
|
$1.41M |
|
$7.07M |
|
$-6.97M |
|
$-6.97M |
|
$-6.97M |
|
7.24M |
|
| Cash Flow Statement Financials | |
$-0.03M |
|
-- |
|
-- |
|
$0.12M |
|
$0.09M |
|
$-0.03M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.25 |
|
-0.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
2.60% |
|
2.60% |
|
-185.43% |
|
3.26% |
|
$-0.96 |
|
$-0.00 |
|
$-0.00 |
|